文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 工程科技 > 能源/化工 > Liposomes and virosomes as delivery systems for antigens
侵权投诉

Liposomes and virosomes as delivery systems for antigens

纳米生物技术,无机纳米材料,有机纳米材料,纳米药物研究方面的研究文献,上学时读的文献,现在没用了,放在电脑里占内存,丢掉有点可惜,现免费分享给大家。

Liposomes and virosomes as delivery systems for antigens

Liposomes and virosomes as delivery systems for antigens

Liposomesandvirosomesasdeliverysystemsforantigens,nucleicacidsanddrugs

Lipid-basedvesiclesareaverypromisingapproachtotreatdiseasessuchascancer,chronicinfectionsand

auto-immunity.Moderndrugencapsulationmethodsallowef cientpackingoftherapeuticsubstancesinsideliposomes,therebyreducingthesystemictoxicityofthedrugs.Speci ctargetingcanenhancethetherapeuticeffectofthedrugsthroughtheiraccumulationatthediseasedsite.Inthevaccine eld,theintegrationoffunctionalviralenvelopeproteinsintoliposomeshasledtoanantigencarrieranddeliverysystemtermedavirosome,aclinicallyprovenvaccineplatformforsubunitvaccineswithanexcellentimmunogenicityandtolerabilitypro le.

Addresses

BernaBiotechLtd,Rehhagstrasse79,CH-3018,Berne,SwitzerlandÃ

e-mail:diana.felnerova@bernabiotech.com

¨ckandChristianMoserDianaFelnerovaÃ,Jean-Franc¸oisViret,ReinhardGlu

autoimmunediseases,aswellashormonaldysregulation.

Sophisticatedformulations(e.g.PEGylated‘stealth’lipo-somes)havebeendevelopedandtheirsuperiorpropertiesdemonstratedwithregardtostability,pharmacokinetics,biodistributionandtoxicity.Despiteextensivestudiesandsigni cantimprovementsinthetechnologyoverthepastthreedecades,thecommercialsuccessofliposometechnologyisstilllimitedexceptforcosmeticproductsthatarenotdiscussedhere.Onlyfourliposomalformula-tionshavereachedthemarketforthedeliveryofdrugsviaintravenousadministration(Table1).Liposomalformu-lationsofseveralsubstancessuchascaryostatics,anti-biotics,photosensitizers,enzymes,hormones,cytokinesandnucleicacids(e.g.oligonucleotidesforgenedelivery)arecurrentlyinpreclinicalandclinicaldevelopmentwithpromisingresults(Tables2and3).Theuseofliposometechnologyingenetherapyhasbeenextensivelyinves-tigated,butthelowef ciencybothofgenetransferandexpressioninvivoremainsthemajorhurdletosuccessfulapplication.Withregardtovaccinesliposomes,andinparticulartheso-calledvirosomes,possessattractivechar-acteristicsasavaccinecarrierandadjuvantsystem[3].Virosomesareliposomalformulationsthathaveviralenvelopeproteinsanchoredintheirlipidmembrane.Thesevirus-likeparticleshaveproventobeeffectiveimmunogenswithuniqueadjuvantproperties[4 ].Inaddition,promisingdatahavebeengeneratedwithotherlipid-basedcarrier/adjuvantsystems,suchastransfero-somes(liposomesconsistingofphosphatidylcholineandcholatewithenhancedskinpenetratingpropertiesforcutaneousadministration),archaesomes(liposomespre-paredusingarchaeobacteriamembranelipidsthatarereportedtoinducesuperiorimmuneresponsescompar-abletoimmunizationwithcompleteFreund’sadjuvant),niosomes(non-ionicsurfactantvesicleswithenhancedchemicalstability),cochleates(formedfromnon-vesicu-larbilayersheetsconsistingofphosphatidylethanola-mine,phosphatidylserineandcholesterolintercalatedbycalciumions)orproteosomes(preparedbyrecon-stitutionofthebacterialoutermembraneandcom-prisedmainlyfromproteins;theyprovidehighim-munogenicity)[5].

CurrentOpinioninBiotechnology2004,15:518–529ThisreviewcomesfromathemedissueonPharmaceuticalbiotechnology

EditedbyCarlosAGuzmanandGioraZFeuersteinAvailableonline28thOctober20040958-1669/$–seefrontmatter

#2004ElsevierLtd.Allrightsreserved.DOI10.1016/j.copbio.2004.10.005

AbbreviationsAPCantigen-presentingcellHAhemagglutininIRIVimmunopotentiatingreconstitutedin uenzavirosomesMHCmajorhistocompatibilitycomplexPEGpolyethyleneglycol

Introduction

Liposomesarevesiclesofvaryingsizeconsistingofasphericallipidbilayerandanaqueousinnercompartmentthataregeneratedinvitro.Thedistinctadvantageofliposomesistheirabilitytoencapsulatevariousmaterialscombinedwiththeirstructuralversatility.In1965,Banghametal. rstusedaliposomalstructureasamodeltostudytheeffectofnarcoticsonlipidbilayermembranes[1].Nineyearslater,AllisonandGregoriadisdescribedtheuseofasimilarliposomalsystemasanimmunologicaladjuvant[2].

Sincetheseearlyexperiments,liposomeshavebecomeanestablishedcarrieranddeliverysysteminthe eldofpharmaco-andimmuno-therapy.Liposomalcarriershavebeenusedforthetreatmentofcancer,infectiousand

CurrentOpinioninBiotechnology2004,15:518–529

Advantagesofliposomaldeliverysystems

Twoofthekeyproblemsofpharmaco-/immuno-therapy—biodistributionandtargeting—canbeaddressedand,atleastpartially,solvedbytheuseofliposomalformulations.Aliposomecanprotectitspay-load(e.g.anactivedrug)fromtheenvironment(e.g.inblood)andviceversa,untilcontrolledreleaseoccursatthetargetsite.Thelipidmembraneanditssurfaceare

doc.guandang.net

第1页

你可能喜欢

热门文档

相关文档

  • Intelligent Drug Delivery Systems

    as monoclonal antibodies, liposomes, polymers, dendrimers, micelles, and ...to the delivery of antigens to dendritic cells for active tumor immunotherapy...

  • Intelligent Drug Delivery Systems

    as monoclonal antibodies, liposomes, polymers, dendrimers, micelles, and ...to the delivery of antigens to dendritic cells for active tumor immunotherapy...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email